Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients.
Sven Heiko LoosenBjörn-Erik Ole JensenChristian TanislavTom LueddeChristoph RoderburgKarel KostevPublished in: Infection (2022)
Lipid metabolism disorders and obesity represent age-independent risk factors for the development of LCS, suggesting that metabolic alterations determine the risk for unfavorable disease courses along all phases of COVID-19.